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Summary
Background: The spindle assembly checkpoint (SAC) arrests
cells when kinetochores are unattached to spindle microtu-
bules. The signaling pathway is initiated at the kinetochores
by one SAC component, Mad2, which catalyzes the initial
steps of the cascade via the conformational dimerization of
its open and closed conformers. Away from kinetochores,
the dimerization surface of Mad2 has been proposed, based
on data in vitro, to either interact with SAC activators or inac-
tivators and thus to contribute to SAC activation or silencing.
Here, we analyze its role in vivo.
Results: To analyze the putative pathway downstream of
the kinetochores, we used two complementary approaches:
we activated the SAC ectopically and independently from
kinetochores, and we separated genetically the kinetochore-
dependent and independent pools of Mad2. We found that
the dimerization surface is required also downstream of kinet-
ochores to mount a checkpoint response.
Conclusion: Our results show that away from kinetochores
the dimerization surface is required for stabilizing the end-
product of the pathway, the mitotic checkpoint complex.
Surprisingly, downstream of kinetochores the surface does
not mediate Mad2 dimerization. Instead, our results are
consistent with a role of Mad3 as the main interactor of
Mad2 via the dimerization surface.Introduction
The spindle assembly checkpoint (SAC) is activated by the
presence of kinetochores unattached to microtubules and by
the ensuing lack of tension between sister chromatids [1, 2].
The target of the checkpoint is the anaphase promoting com-
plex or cyclosome (APC/C), a ubiquitin ligase whose function
is required for the degradation of mitotic cyclins and securin7These authors contributed equally to the work
*Correspondence: andrea.ciliberto@ifom.eu(primarily Clb2 and Pds1 in budding yeast, respectively)
whencells enter anaphase [3]. TheSACdoesnot directly inhibit
APC/C, but it targets Cdc20, one of its coactivators [4]. SAC
activation induces the formation of a complex between
Cdc20 and three components of the pathway, Mad2, Mad3,
and Bub3. The tetrameric complex Cdc20:Mad2:Mad3:Bub3,
known as the mitotic checkpoint complex (MCC), binds the
APC/C [5]. The resulting complex, APC/CMCC, cannot target
securin and mitotic cyclins for degradation.
A complex formed by the SAC components Mad1 andMad2
(Mad1:Mad2) plays a crucial role in the generation of the
MCC [6]. Mad1:Mad2 binds to unattached kinetochores and
facilitates the binding of Mad2 to Cdc20, likely the first step
in the formation of the MCC [6]. Depending on the conforma-
tion of the so-called safety belt, the C-terminal 50 residues,
Mad2 is defined as either open or closed (O-Mad2 and
C-Mad2) [7]. In cells, monomeric Mad2 is present in the open
conformation, but O-Mad2 transits to the closed conformation
when it binds its substrates, either Mad1 or Cdc20. Given the
extensive structural rearrangement required for the conver-
sion between O-Mad2 and C-Mad2, Mad2 binding to
Cdc20 is very slow, as measured in vitro [8]. The Mad1:
C-Mad2 complex catalyzes the structural conversion of
O-Mad2 required for Cdc20/Mad2 binding. According to the
‘‘Mad2-template model,’’ the catalytic reaction requires the
transient binding of Mad1:C-Mad2 (the template C-Mad2)
with O-Mad2, which occurs via dimerization of O-Mad2
with C-Mad2 in the Mad1:Mad2 complex [6]. The Mad1:
C-Mad2:O-Mad2 intermediate isbelieved to releaseamolecule
of ‘‘active’’ Mad2, not closed yet, but more prone to closing
than O-Mad2 on encountering Cdc20. The binding reaction
will give rise to the final conversion into C-Mad2 (the copy
C-Mad2) (see Figure S1A available online).
Mad2 dimerization mutants have been instrumental for
understanding the molecular mechanisms taking place during
SAC signaling. In humans, Phe141 (Phe134 in budding yeast)
lies at the core of the dimerization surface. Accordingly,
Alanine point mutations of Phe141 impair the dimerization
between C-Mad2F141A and O-Mad2 [7]. Crucially, the effect
of the mutation is asymmetric because O-Mad2F141A can
bind to wild-type (WT) C-Mad2 as efficiently as O-Mad2. In
budding yeast, the mad2F134A allele does not complement
the deletion of the MAD2 gene, showing that Mad2 dimeriza-
tion is required for SAC signaling [9]. This result can be inter-
preted in light of the Mad2-template model if Mad2F134A
binding to Mad1 creates a Mad1:C-Mad2F134A complex that
cannot dimerize and thus cannot prime O-Mad2F134A for
binding to Cdc20 (Figure S1B, where we collectively refer to
this part of the pathway as ‘‘kinetochore-dependent’’) [10].
In principle, the checkpoint deficiency of the Mad2F134A
mutant could also be due to a role of Mad2 downstream
from kinetochores, independently from Mad1:C-Mad2 dimer-
ization (‘‘kinetochore-independent’’ in Figure S1B). Indeed, it
has been pointed out that the Cdc20:C-Mad2 complex is
structurally a copy of the Mad1:C-Mad2 template and is there-
fore predicted to contribute to the conversion of O-Mad2 into
C-Mad2 via Mad2 dimerization. Evidence supporting this
hypothesis comes from experiments in vitro [8]. However,
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Figure 1. Mad2 Overexpression Can Induce an
Arrest in Metaphase Independently from Mad1
(A) Cells were synchronized in G1 with a factor
and released in galactose. a factor was re-added
at hr 2. In parentheses, the number of copies of
GAL1-MAD2: 1X (yAC80), 2X (yAC81), and 3X
(yAC82). WT cells (yAC1) were also analyzed.
DNA content was analyzed by FACS; samples
where more than 80% of cells have a 2C DNA
content are shown in light gray.
(B) Cells were collected after 4 hr growth in galac-
tose. Mad2 levels were analyzed by western blot
with anti-Mad2 antibodies. Left shows a strain
carrying one copy of GAL1-MAD2 (yAC80),
MAD2 WT (yAC1), and mad2D (yAC5). Right
shows strains carrying multiple copies of GAL1-
MAD2: 1X (yAC40), 2X (yAC106), and 3X (yAC41).
Mad2 Dimerization Surface away from Kinetochores
1901the discovery that the dimerization interface of C-Mad2 is
implicated in the binding of other proteins, such as p31comet
(limitedly to metazoans) [9, 11] and BubR1/Mad3 [12, 13],
suggests that this interface might be capped by other proteins
away from kinetochores.
Here, we investigate SAC signaling downstream of kineto-
chores and show that the dimerization interface of Mad2
away from kinetochores is primarily required for stabilizing
the MCC. Our results point to a possible role of Mad3 as the
key interactor of Mad2 for helping MCC stabilization, whereas
they do not support a role for Mad2 dimerization in amplifying
the SAC signal away from kinetochores.
Results
Increasing Mad2 Overexpression Gradually Induces
a Mitotic Arrest Independently from Mad1
To analyze the role of Mad2 dimerization surface indepen-
dently from Mad1:C-Mad2, we aimed at activating the SACectopically in mad1D cells. In many
systems, the overexpression of Mad2
causesanarrest inmetaphase for several
hours [14–16], followed by a process
named adaptation in which arrested
cells leave mitosis and reenter into G1.
In fission yeast, the mitotic delay caused
by overexpression of Mad2 is indepen-
dent from Mad1 [15], likely because the
amount of active Mad2 that forms spon-
taneously, negligible in physiological
concentrations of Mad2, is enough to
sequester Cdc20. We set out to verify
whether this was the case in budding
yeast as well (reactions in the ‘‘kineto-
chore-independent’’ box of Figure S1A).
To overexpress Mad2, we integrated
its coding sequence under the galac-
tose-inducible GAL1 promoter in the
yeast genome (GAL1-MAD2). We then
produced strains carrying one, two, or
three copies of GAL1-MAD2 in a
mad1D mad2D background. Cells were
arrested in G1 with a factor and released
in galactose-containingmedium.a factor
was re-added 2 hr after the release to
arrest them before entering the nextcell cycle. We referred to a population as ‘‘mitotic’’ when
more than 80% of cells have a 2C DNA content as detected
by FACS. We then identified as ‘‘arrested in mitosis’’ a cell
population that remains mitotic after WT cells have entered
G1. One copy of GAL1-MAD2 was unable to induce a pro-
longed mitotic arrest, but with two copies, the cells were
arrested in mitosis for 1.5 hr. Three copies induced an arrest
that lasted for 5 hr (Figure 1A). The stabilization of Pds1, one
of the substrates of APC/CCdc20, confirmed that mitotic cells
were arrested in metaphase (Figure S1C). The time cells spent
in mitosis increased with the number of copies ofGAL1-MAD2
and thuswith the levels ofMad2, with one copy ofGAL1-MAD2
inducing approximately a 20-fold increase of Mad2 compared
to the endogenous promoter (Figure 1B). Finally, we confirmed
that the presence of Mad1 does not affect the outcome of
Mad2 overexpression (Figure S1D).
We conclude that by overexpressing Mad2, it is possible
to arrest cells in metaphase, independently from the presence
of Mad1.
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Figure 2. Mad2 Overexpression Induces a
Genuine SAC Independently from Kinetochores
(A) WT (yAC1), GAL1-MAD2 (3X) (yAC41), GAL1-
MAD2 (3X) mad3D (yAC436), and GAL1-MAD2
(3X) bub3D (yAC454) cells were treated as in Fig-
ure 1A. Samples where more than 80% of cells
have a 2C DNA content are shown in light gray.
(B and C) Cells were synchronized in G1
with a factor and released either in galactose
(yAC396, yAC401, yAC394, yAC424, yAC383) or
in nocodazole (yAC398, yAC363, yAC387). One
hundred min after release, protein extracts were
prepared and analyzed by immunoblotting with
indicated antibodies either directly (total ex-
tracts) or after Cdc20-Myc immunoprecipitation
with anti-Myc antibodies (Myc IP).
(D) GAL1-MAD2 (3X) BUB1-GFP cells (yAC532)
were synchronized in G1 and released in raffinose
either with nocodazole or galactose. Figures
were taken after 180 min.
(E) GAL1-MAD2 (3X) ndc10-1 (yAC262) cells were
arrested in G1 by a factor, and released at 37C in
nocodazole and either glucose or galactose.
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The Mad2 overexpression data are consistent with a scenario
where high levels of Mad2 can spontaneously induce the
formation of sufficient Cdc20:C-Mad2 seeds for the formation
of a complete and activeMCC through the recruitment of addi-
tional components (Mad3 and Bub3). In this case, the absence
of additional components of the MCC should impair the
ectopic activation of the checkpoint even in the presence of
Mad2 overexpression. We thus tested whether high levels ofMad2 can induce a mitotic delay in the
absence of Mad3 or Bub3. We synchro-
nized mad3D GAL1-MAD2 (3X) and
bub3D GAL1-MAD2 (3X) cells in G1
and released them in galactose-contain-
ing medium. In both cases, we did not
observe any mitotic delay compared to
the WT (Figure 2A). GAL1-MAD2 (3X)
bub3D cells divided more slowly than
GAL1-MAD2 (3X), likely because of the
deletion of BUB3. Thus, Mad2 overex-
pression relieves a requirement for a
component, Mad1, which is known to
act upstream of Mad2 activation, but
does not relieve a requirement for other
SAC components that work with Mad2
in the checkpoint effector MCC.
To confirm that the arrest due toMad2
overexpression was caused by MCC
formation, we compared the amount
of MCC present in WT cells arrested
inmetaphase by treatmentwith nocoda-
zole or by Mad2 overexpression [GAL1-
MAD2 (3X)]. The metaphase arrest was
evaluated by the stabilization of the
mitotic cyclin Clb2 (Figures 2B and
2C) and was confirmed by DNA content
(data not shown). As a read-out of MCC
formation, we measured the amount
of Mad3 or Bub3 bound to Cdc20 by
immunoprecipitation. The levels of
Cdc20-bound Mad3 and Bub3 weresimilar in the two settings (Figures 2B and 2C), further confirm-
ing thatMad2 overexpression induces a bona fide activation of
the SAC independently from Mad1.
Ectopic Activation of the SAC Does Not Require
Kinetochores
Our hypothesis is that Mad2 overexpression induces the SAC
directly, by providing an initial seed for MCC formation. How-
ever, it is also possible that the overexpression of Mad2
Figure 3. Ectopic SAC Activation Is Not Efficient
in Dimerization Impaired Mad2 Mutants
The fraction of cells with 2C DNA content as
measured by FACS. After a factor synchroniza-
tion and release in galactose, a factor was re-
added at hr 2. Strains had different number of
copies of GAL1-MAD2: (left) 1X (yAC80), 2X
(yAC81), and 3X (yAC82); (right) GAL1-
mad2F134A 2X (yAC157), 4X (yAC234), >5X
(yAC233), and >6X (yAC232). WT MAD2 (yAC1)
was used as a control.
Mad2 Dimerization Surface away from Kinetochores
1903impairsmicrotubule-kinetochore attachment, triggering a SAC
response. To exclude this possibility, we used a fluorescently
tagged version of Bub1 (Bub1-GFP) as an indicator of SAC
signaling at the kinetochores [17]. Bub1, another element of
the SAC pathway, localizes at kinetochores when the latter
are not attached to microtubules. When cells are treated with
nocodazole, Bub1-GFP localizes as expected at the kineto-
chores in metaphase-arrested cells (appearance of Bub1-
GFP nuclear foci), whereas Mad2 overexpression induces a
metaphase delay in the absence of Bub1 localization at the
kinetochores (Figure 2D). To further confirm thatMad2 overex-
pression does not impact on microtubule-kinetochore attach-
ment, we have analyzed the viability of cells overexpressing
Mad2 and lacking Mad3. GAL1-MAD2 (3X) mad3D are not
delayed in the cell cycle (Figure 2A) and thus, if overexpressed
Mad2 affected the microtubule-kinetochore interaction, we
would expect these cells to have reduced viability when
grown in galactose. We have instead observed that both
growth rate and viability of GAL1-MAD3 (3X) mad3D are very
similar to WT cells (Figures S2A and S2B), further supporting
the conclusion that Mad2 overexpression does not affect
microtubule-kinetochore attachment.
Thus, Mad2 overexpression does not cause an overt defect
in kinetochore-microtubule attachment, suggesting that the
arrest induced by Mad2 overexpression develops indepen-
dently of kinetochores. To test this hypothesis, we induced
an ectopic SAC arrest in cells lacking kinetochores altogether.
Conditional disassembly of kinetochores can be obtained by
using a temperature-sensitive mutant of Ndc10, a fundamental
structural component of the kinetochores [18, 19]. Indeed,
GAL1-MAD2 (3X) ndc10-1 cells grown at 37C in nocodazole
and glucose (i.e., GAL1 promoter repressed) are unable to
activate the SAC and enter another round of S phase, as
seen by 4C DNA content. However, cells grown at 37C in
galactose (i.e., GAL1 promoter active) and nocodazole are
arrested in mitosis regardless of the ndc10-1 mutation, likely
due to the ectopic activation of the SAC independently of
kinetochores (Figure 2E).
These observations strongly support our contention that
Mad2 overexpression induces a mitotic arrest by producing
MCC independently from Mad1 and kinetochores.
A Dimerization-Impaired Mutant Fails in Ectopically
Activating the SAC
Having established a system where SAC activation can be
induced independently from kinetochores, we wanted to
test whether the dimerization surface of Mad2 plays a roleaway from the kinetochores. We
reasoned that if the dimerization defec-
tive Mad2F134A was only impaired in
relaying the Mad1:C-Mad2 signal at thekinetochores, its overexpression should produce the same
ectopic activation of the SAC as the overexpression of Mad2
WT. If instead the dimerization surface ofMad2 is also required
downstream from Mad1:C-Mad2, we would expect a defect in
SAC activation. mad1D mad2D GAL1-mad2F134A cells were
synchronized in G1 and released in galactose containing
medium. FACS analysis showed that to obtain merely
a moderate delay in mitosis, more than five copies of GAL1-
mad2F134A were required (Figure 3), an effect weaker than
what produced by three copies of GAL1-MAD2. This quantita-
tive result is not due to different levels of Mad2 expression,
because the same number of copies of GAL1-mad2F134A and
GAL1-MAD2 expresses similar amounts of Mad2 (Figure S3).
In conclusion, the overexpression of Mad2F134A shows that
the dimerization surface plays a fundamental role in SAC
signaling independently from kinetochores.
Engineering Strains Carrying Two Pools of Mad2
(2-Pool Strain)
We then set out to confirm that the C-Mad2 dimerization
surface mutated in Mad2F134A plays a fundamental role away
from kinetochores also when Mad2 is expressed at endoge-
nous levels and kinetochores signal normally. Testing this
idea requires maintaining signaling from Mad1:C-Mad2 while
at the same time interfering with the remaining Mad2 directed
to Cdc20. To this aim, it is necessary to create two genetically
distinct populations of Mad2: one unable to interact with Mad1
but capable to bindCdc20 and a second one that signals to the
first via Mad1 binding. An important precondition for the engi-
neering of strains that meet this condition is that the Mad1:
Mad2 complex is extraordinarily stable, so that its dissociation
can be neglected within the timing of observation [20, 21].
We thus engineered yeast cells with two distinct pools of
Mad2 (2-pool strain): WT Mad2, which interacts preferentially
with Cdc20, and Mad2-kinetochore (Mad2KT), capable to
bind efficiently to Mad1 (Figure S4A). To ensure specificity
between Mad2KT and Mad1, we took advantage of differences
in the Mad2 binding motifs of Mad1 and Cdc20 in different
species. Specifically, we were able to demonstrate in vitro
that human Mad2 is unable to bind with high affinity to the
Mad2-binding motifs of Cdc20 or Mad1 from Saccharomyces
cerevisiae. Conversely, yeast Mad2 is unable to bind tightly to
the Mad2-binding motifs of human Cdc20 or Mad1 (L.N. and
A.M., unpublished data). To identify crucial residues respon-
sible for species-specific specificity of the interaction of
Mad2 with Mad1, we carried out a co-occurrence analysis
[22]. This identified a set of Mad2 residues whose occurrence
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Figure 4. The 2-Pool Strain
(A) Protein extracts from cells of the indicated genotypes (yAC1217, yAC1208, yAC1276, yAC1282) were analyzed by immunoblotting with anti-myc or
anti-Mad2 antibodies either directly (total extracts) or after Mad1KT-13Myc immunoprecipitation with anti-Myc antibodies (Myc IP).
(B) Micrographs of cells of the indicated genotypes (yAC1513, yAC1544) taken 3 hr after release from a factor in nocodazole.
(C and D) Cells of the indicated genotypes (C: yAC1070, yAC1269, yAC1274, yAC1272, yAC1286; D: yAC1269, yAC1471, yAC1481) were arrested in G1
with a factor and released in nocodazole. Samples were collected at the indicated time points to score sister chromatids separation.
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1904correlates strictly with the presence of mutations in the Mad2-
binding motifs of Mad1 (Text S1).
Next, we introduced human specific mutations to
‘‘humanize’’ ScMad1 (defined as Mad1KT) and ScMad2
(Mad2KT). The mutations in Mad1 are located in the Mad2-
binding region [21]. The latter was modified by replacing the
yeast residues in positions 581–588 (RILQLRDG) with the
equivalent mammalian residues (KVLHMSLN) (Figure S4B).
We also modified ScMad2 in the Mad1-binding region (substi-
tutions I62V and D164E). These substitutions do not affect the
dimerization interface, which is very well conserved in evolu-
tion and which mediates, as previously shown, cross-species
dimerization [10].
We tested the specificity of Mad1KT/Mad2KT binding by
comparing the amount of Mad1KT-bound Mad2 in mad1D
mad1KT mad2D MAD2 and mad1D mad1KT mad2D mad2KT
cells. Immunoprecipitation showed that Mad2KT binds
Mad1KT z2 times better than Mad2 (Figure 4A, lanes 3
and 4), suggesting that we obtained a good, albeit not perfect,
separation of the two pools of Mad2. As an additional test,
we usedMad2 tagged with GFP (a gift from the Tanaka labora-
tory) to evaluate whether Mad2 binding to kinetochores is
decreased by the presence of Mad1KT and Mad2KT. In cells
treated with nocodazole, we observed a clear reduction of
kinetochore signal inmad1Dmad1KTmad2KTMAD2-GFP cells
as compared to MAD2-GFP cells (Figure 4B).In conclusion, we took advantage of the species-specificity
of Mad2 binding sites in Mad1 and Mad2 to produce ‘‘human-
ized’’ versions of Mad1 and Mad2 (Mad1KT and Mad2KT) that
interact specifically with each other.
BothMad2KT andMad2WTAre Required for anOperational
Checkpoint
Both catalysis ofMad1:C-Mad2 at the kinetochores andMad2/
Cdc20 binding away from kinetochores are required for a
proficient checkpoint. Although Mad2 WT can bind Cdc20
efficiently, it is not proficient in Mad1KT binding. We thus ex-
pected the mad1D mad1KT MAD2 strain to be checkpoint
deficient and to require Mad2KT to restore the checkpoint.
To test checkpoint proficiency, we followed sister
chromatids separation directly, by visualizing with GFP the
pericentromeric region of chromosome V [23, 24]. Cells were
synchronized by a factor arrest and released in nocodazole
to activate the checkpoint. As indicated by the kinetics of sister
separation, cells expressing only WT Mad2 are impaired in
mounting a checkpoint response (50% of mad1D mad1KT
MAD2 (2X) have entered anaphase after 4 hr, compared to
10% for WT cells, Figure 4C). The partial recovery of the SAC
compared tomad1D can be relatedwith the previous observa-
tion that Mad2 binding of Mad1KT is decreased compared to
Mad2KT but not completely abolished (Figure 4A). Crucially,
the functionality of the checkpoint increased greatly after we
Figure 5. Overexpression of Mad2R126A Is Similar
to that of Mad2 WT
(A) Upper panel shows that in Mad2 WT,
Cdc20:C-Mad2 can interact both with O-Mad2
and with Mad3. Middle panel shows that
Cdc20:C-Mad2F134A (red star) can interact with
neither of the two. Lower panel shows that
Mad2R126A (black star) cannot dimerize but can
bind Mad3.
(B) Cells were treated as in Figure 1A. Upper
panel shows GAL1-MAD2 (1X [yAC80], 2X
[yAC81], and 3X [yAC82]), and lower panel shows
GAL1-mad2R126A (1X [yAC735], 2X [yAC737], and
3X [yAC741]). The plot shows the fraction of cells
with 2C DNA content as measured by FACS. WT
MAD2 (yAC1) was used as control.
Mad2 Dimerization Surface away from Kinetochores
1905replaced one copy of MAD2 with one copy of mad2KT (which
by itself is unable to recover the full checkpoint arrest). In 75%
ofmad1Dmad1KTmad2KTMAD2cells, sister chromatids sepa-
ration is arrested for at least 4 hr although cells do not express
more Mad2 thanmad1Dmad1KT MAD2 (2X) (Figure S4C).
In summary, in the 2-pool strain the kinetochore-indepen-
dent pool of Mad2 is unable to mount a full checkpoint
response, which requires the contribution of the kineto-
chore-dependent pathway.
The Mad2 Dimerization Surface Is Needed Away from
Kinetochores
Weused the 2-pool strain to investigate the role ofMad2dimer-
ization downstream of kinetochores by replacing WT MAD2
with mad2F134A. The F134A mutation impairs the dimerization
surface of Mad2 when the latter is in the closed conformation
but O-Mad2F134A binds C-Mad2 as efficiently as O-Mad2 [7].
For this reason, in themad1Dmad1KTmad2KTmad2
F134Astrain,
the signal emanating from the kinetochores is not expected to
be silenced: O-Mad2F134A can bind to Mad1:C-Mad2KT and
thus can be primed for the binding with Cdc20. However,
after Mad2F134A binds Cdc20 and turns into the closed confor-
mation, it might be unable to interact with additional molecules
required for MCC formation (Mad2F134A acts only in the kineto-
chore-independent box of Figure S4A). If this interaction were
important for SAC signaling, we would expect to observe
a checkpoint defect. Indeed, we observed that mad1D
mad1KT mad2KT mad2
F134A is checkpoint deficient (similar to
mad1D, Figure 4D). Our interpretation of the previous results
only holds if Mad2F134A does not significantly bind to Mad1KT,because binding ofMad2F134A toMad1KT
would silence SAC signaling at kineto-
chores. We thus tested Mad2F134A
binding to Mad1KT and found it to be
negligible (Figure S4D, lanes 1 and 2).
In conclusion, these data confirm the
results from Mad2 overexpression that
the dimerization surface of C-Mad2
plays a role independently of Mad1,
presumably when C-Mad2 is bound to
Cdc20.
Mad2 Dimerization Does Not Play
a Relevant Role Downstream of
Kinetochores
Data obtained in vitro have shown that
several proteins interact with the dimer-ization interface of Mad2. In metazoans, p31comet, a negative
regulator of the SAC whose homolog in yeast is unknown,
interacts with Mad2 via the dimerization interface [9, 11]. Our
results in two different experimental systems show that
Mad2F134A is impaired in SAC activation independently from
kinetochores, ruling out the relevance at this stage of an
interaction with a putative negative regulator of the SAC.
The results could instead be explained by the inability of
Cdc20:C-Mad2F134A to interact with MCC components. The
recently determined structure of the MCC [13] shows that
the F134A mutation might impair the interaction between
Cdc20:C-Mad2 and Mad3. By superimposing the structure
of C-Mad2:Mad3 in the MCC with the C-Mad2:O-Mad2
dimer [7], it is also clear that the F134A mutation could impair
the binding of Cdc20:C-Mad2 with O-Mad2. In summary,
structural data show that the phenotype of the F134A
mutation could be due to the impaired interaction with either
Mad3 or O-Mad2.
To estimate the relevance of O-Mad2 binding in ectopic SAC
activation, we need a separation of function mutant of Mad2
that cannot dimerize but preserves the capability to bind
Mad3 (Figure 5A, lower panel). mad2R126A fulfills all require-
ments: the structure of the MCC from fission yeast shows
that Arg133 (the equivalent residue in fission yeast and in
Homo sapiens of Arg126) does not take part in Mad3 binding
to Cdc20:C-Mad2 [13]. However, although the product of
Hs-mad2R133A can acquire both open and closed conforma-
tions, the two mutant conformers do not form dimers as the
R126A substitution affects the dimerization surface of both
C-Mad2R126A and O-Mad2R126A [25]. Importantly, in budding
Figure 6. Overexpression of Mad2LQFA Is Less Capable to Induce a Checkpoint Arrest than Mad2L7Q
(A) Upper panel shows that the binding of Cdc20/Mad2 is favored (blue arrow) due to the L7Q mutation (purple star) and that Mad2 cannot dimerize. Lower
panel shows that in the mad2LQFA mutant (gray star) both dimerization and Mad3 binding are impaired.
(B) Cells were synchronized in G1 with a factor, and released in galactose to induce the expression of GAL1-mad2L7Q (1X [yAC83], 2X [yAC84], and 3X
[yAC86]) and GAL1-mad2LQFA (1X [yAC323], 2X [yAC324], and 3X [yAC326]). a factor was re-added at hr 2. The plot shows the fraction of cells with 2C
DNA content as measured by FACS.
(C) mad1D mad2D (yAC5) and GAL1-mad2L7Q (3X) either with (yAC86) or without MAD3 (yAC569) were treated and analyzed as in (B).
(D) Cells were arrested in G1with a factor and released in galactose (GAL1-MAD2 [3X] [yAC82],GAL1-mad2F134A [4X] [yAC234],GAL1-mad2L7Q [3X] [yAC86],
GAL1-mad2LQFA [3X] [yAC326], andGAL1-mad2L7Q [3X]mad3D [yAC569]). At 80 min, protein extracts were collected and analyzed by immunoblotting with
the indicated antibodies either directly (total extracts) or after Mad2 immunoprecipitation with anti-Mad2 antibodies (Mad2 IP).
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cient, likely as a result of the impaired dimerization [10].
We thus compared the effect ofMAD2 andmad2R126A over-
expression inmad1Dmad2D cells to evaluate the role of Mad2
dimerization downstream of kinetochores. Our results show
that overexpression of mad2R126A and MAD2 have a similar
effect, which is much stronger thanmad2F134A overexpression
(Figures 3 and 5B). We conclude that Mad2 dimerization does
not contribute significantly to an ectopic checkpoint arrest
induced by Mad2 overexpression. We also predict that the
phenotype of mad2F134A is mainly due to impairment in Mad3
binding.
Mad3 Binding Might Contribute to the Ectopic Activation
of the SAC
We next wanted to confirm that, independently from Mad2
dimerization, the lack of Mad3 binding affects the kineto-
chore-independent pathway. To evaluate the relevance of
C-Mad2/Mad3 binding, we proceeded in two steps. First, we
created Mad2 mutants impaired in dimerization regardless of
an intact F134 residue. Then, we used them to analyze the
effect of the F134A mutation, which in this setting should
impact on Mad3 binding only (Figure 6A). Glutamine point
mutations of Leu7 destabilize O-Mad2 and thus Mad2L7Q
mutants accumulate in the closed-conformation and do not
form dimers [7]. The fact that Mad2L7Q acquires more easily
the closed conformation is mirrored by its higher affinity for
Cdc20 in vivo, because inmammalian cells the overexpressionof an equivalent mutant of Mad2L7Q (i.e., Mad2L13A) induces
amitotic delay [26]. We confirmed this result in yeast, because
when we overexpressed Mad2L7Q in mad2D mad1D cells, we
found that one copy ofGAL1-mad2L7Qwas sufficient to induce
a phenotype stronger than what we have observed with two
copies ofGAL1-MAD2 (compare Figure 6B upper and Figure 3
left). Again, the presence of Mad3 is required for the arrest
(Figure 6C), showing that Mad2L7Q induces a genuine SAC
response and that the L7Q substitution does not affect the
capability of Mad2 to interact with Mad3.
We then combined the L7Q mutation with the F134A muta-
tion in the same allele (mad2LQFA). Phenotypic differences
betweenGAL1-mad2L7Q andGAL1-mad2LQFA can be primarily
attributed to the inability of Mad2LQFA to interact with Mad3
because Mad2 dimerization is already impaired by the L7Q
mutation. Whereas two copies ofGAL1-mad2L7Qwere enough
to induce a SAC arrest, three copies of GAL1-mad2LQFA were
required to achieve a comparable mitotic arrest (Figure 6B,
lower). This quantitative difference suggests that the impaired
binding between C-Mad2 and Mad3 contributes significantly
to the reduced ability of Mad2LQFA to induce an ectopic
checkpoint.
Mad3 Binding Could Help Stabilize the Cdc20:C-Mad2
Complex
From a molecular viewpoint, one interpretation of our data is
that the interaction between C-Mad2 and Mad3 via the F134A
residue is relevant for creating a stable Cdc20:C-Mad2:Mad3
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bound to Cdc20 decreases when the Mad2/Mad3 interaction
is impaired. We thus aimed at testing whether Mad2LQFA binds
Cdc20 less stably than Mad2L7Q due to the missing interaction
with Mad3. Hence, we measured the amount of Cdc20 bound
to Mad2 inmad1Dmad2D GAL1-mad2L7Q andmad1Dmad2D
GAL1-mad2LQFA 80 min after release from a factor, when
most cells were in metaphase as evaluated by spindle
morphology (data not shown). As expected, we observed
more Cdc20:C-Mad2L7Q than Cdc20:C-Mad2LQFA (Figure 6D,
lanes 4 and 5) and WT Mad2 immunoprecipitated more
Cdc20 than Mad2F134A (Figure 6D, lanes 2 and 3). A second
prediction is that Mad2L7Q should not bind Cdc20 effectively
in the absence of Mad3. Indeed, we noticed that without
Mad3 the capability of Mad2L7Q to bind Cdc20 is decreased
to the level of Mad2LQFA (Figure 6D, lanes 4, 5, and 6).
We conclude that in vivo the F134 residue of Mad2 is rele-
vant for stabilizing the Cdc20:C-Mad2 complex likely via the
interaction with Mad3.
Discussion
In this manuscript, we have investigated the SAC pathway
away from kinetochores by analyzing the role of Mad2 dimer-
ization interface. Our results showed that in vivo the F134
residue of Mad2, localized in the dimerization surface, is
required for the formation of MCC independently from
kinetochores.
What Role for Mad2 Dimerization Surface Downstream of
Kinetochores
The recently determined structure of the mitotic checkpoint
complex (MCC) shows that the dimerization surface of
C-Mad2 in the Cdc20:C-Mad2 complex interacts with Mad3,
with the F134 residue playing a pivotal role in the binding
[13]. The very same residue is required for the dimerization
between O-Mad2 and C-Mad2 [7]. Thus we have two potential
interactions of Cdc20:C-Mad2—with O-Mad2 and Mad3—
whose impairment may result in the phenotype of the F134A
mutation.
What could be the rationale for Mad2 dimerization down-
stream of kinetochores? The O-Mad2:C-Mad2 dimer, in
analogy with Mad1:C-Mad2, could be used by Cdc20:
C-Mad2 to prime O-Mad2, help the formation of more
Cdc20:C-Mad2 and amplify the SAC signal in an autocatalytic
fashion (Figure S5). We have previously shown in vitro that
indeed Cdc20:C-Mad2 can induce such a positive feedback
loop [8]. Here, we show data that do not support the presence
of such a circuit in vivo. Mad2 overexpression induces a
gradual increase of cells arrested in mitosis and not the activa-
tion threshold that characterizes positive feedback loops
[Figure 3, left, GAL1-MAD2 (2X) is half-way between (1X) and
(3X)]. Moreover, when we overexpress a separation of function
mutant of Mad2 that can bind to Mad3 but cannot dimerize
(Mad2R126A), we do not see major differences from overex-
pressing Mad2 WT. The result is in agreement with what was
reported by Lau and Murray, who could activate the check-
point equally well by tethering Cdc20 with either Mad2 WT or
aMad2mutant, which carries the R126E and Q127Amutations
[27]. From theMCC structure, we infer that Mad2RQEA is mainly
impaired in Mad2 dimerization, although the Q127A substitu-
tion should affect marginally also Mad3 binding. Notice that,
in previous works, we have also used for in vitro assays the
R126A mutation together with Q127A to create a morepenetrant effect that eliminates the residual dimerization
between Mad2R126A and dimerization competent forms of
Mad2 (e.g., Mad2wt) [10]. However, in the experiments we
present here, cells express Mad2R126A only, and thus the
R126Amutation is sufficient to generatemutants fully impaired
in dimerization.
From the structural data [13] and the Mad2R126A experi-
ments, we conclude that Mad2F134A is less capable to induce
an ectopic SAC activation likely because Cdc20:C-Mad2
cannot interact with Mad3. Further supporting this prediction,
we showed that, in a context where the dimerization of
Mad2 is already minimal (Mad2L7Q), the F134A mutation
further destabilizes the MCC. We thus propose that Mad3
binding to the dimerization interface of C-Mad2 stabilizes the
Cdc20:C-Mad2 complex downstream of kinetochores.
The Role of Mad3 in Cdc20/Mad2 Binding
Mad3 being required to stabilize the Cdc20:C-Mad2 complex
implies that the complex by itself is unstable. This conclusion
might be surprising when we consider the affinities of the
binding reaction as measured in vitro. Using mammalian
homologs of Mad2 and Cdc20, we observed a dissociation
constant in the order ofz100 nM [6, 8]. Given that concentra-
tions of Cdc20 and Mad2 in metaphase are [Cdc20]z100 nM
and [Mad2]z400 nM [28], the concentration of free Cdc20 is
expected to be quite low. Even more so under Mad2 overex-
pression: because every copy of GAL1-MAD2 leads to
a z320 increase of [Mad2], we would expect only z1% of
Cdc20 free in a GAL1-MAD2 (1X). In such conditions, cells
should be well arrested in metaphase, which is not the case.
We thus conclude that a larger fraction than 1% of Cdc20 is
free fromMad2with onecopyofGAL1-MAD2. Thediscrepancy
between the measurement in vitro and the observed pheno-
type in vivo could be due to putative active mechanisms at
place to destroy the Cdc20:C-Mad2 complexes, as observed
in mammals [29] albeit not in yeast. The binding of Cdc20
requires a large conformational change of Mad2, and very
few Cdc20:C-Mad2 complexes could form if the dissociation
were faster than the closing time of Mad2 around Cdc20. The
role of Mad3 could be to prevent suchmechanisms to destabi-
lize the Cdc20:C-Mad2 complex before the binding is com-
plete. The lower efficiency of Mad2F134A in inducing a SAC
arrest compared to Mad2 WT would thus be the result of the
active dissociation processes not contrasted by the presence
of Mad3. Even the few Cdc20:C-Mad2F134A formed would be
quickly destabilized creating free Cdc20 and O-Mad2, which
again would rebind only very slowly. We can speculate that in
the extreme case when Cdc20 and Mad2 affinity is infinitely
high, the mutation in the dimerization interface should bear
no consequences because dissociation would be ineffective,
and Mad2 would have enough time to bind Cdc20. This is
indeed what Lau and Murray observe, using a different allele
of Mad2 mutated in the dimerization interface [27].
Is then Mad3 role limited to stabilizing Cdc20:C-Mad2? In
our system, Mad3 is not dispensable to generate an ectopic
SAC, even in the presence of large overexpression of
Mad2L7Q. In Lau and Murray’s system, where Cdc20 and
Mad2 are tethered together, Mad3 is dispensable (although it
is not so in a sizeable fraction of cells) [27]. This apparent
discrepancymight be explained by the strength of the putative
mechanisms that dissociate Cdc20:Mad2, so that even three
copies ofGAL1-MAD2L7Q cannot cope with them as efficiently
as tethering Cdc20 and Mad2 molecules together. Surely,
additional work is needed to understand whether Mad3 plays
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in agreement with previous results [30, 31].
In conclusion, our results suggest that the very same dimer-
ization interface of Mad2 is required for two different, yet
fundamental, consecutive steps of SAC signaling: at the kinet-
ochores for priming Cdc20/Mad2 binding, away from kineto-
chores for stabilizing this complex.
Experimental Procedures
Strains, Media, and Reagents
All yeast strains (Table S1) were derivatives of or were backcrossed at least
three times to W303 (ade2-1, trp1-1, leu2-3,112, his3-11,15, ura3, ssd1).
Cells were grown in YEP medium (1% yeast extract, 2% bactopeptone,
50 mg/l adenine) supplemented with 2% glucose (YEPD), 2% raffinose
(YEPR), or 2% raffinose and 2% galactose (YEPRG). Unless otherwise
stated, a factor and nocodazole were used at 3 mg/ml and 15 mg/ml, respec-
tively. Re-addition of a factor was at 20 mg/ml. Synchronization experiments
were carried out at 25C, and galactose was added 1 hr before release from
a factor. See Supplemental Experimental Procedure for plasmid construc-
tion, genetic manipulations, and other experimental details.
Supplemental Information
Supplemental Information includes five figures, one table, Supplemental
Text, and Supplemental Experimental Procedures and can be found with
this article online at http://dx.doi.org/10.1016/j.cub.2012.08.028.
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